HER2 Low Breast Carcinoma Clinical Trials

7 clinical trials for HER2 Low Breast Carcinoma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer — RECRUITING · PHASE2
• ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer — RECRUITING · PHASE1
• PRE-I-SPY Phase I/Ib Oncology Platform Program — RECRUITING · PHASE1
• A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer — RECRUITING · PHASE2
• Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd — RECRUITING · PHASE1
• Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients — COMPLETED

Refine this search